Veradigm FollowMyHealth Named Most Improved Software Product by KLAS

Rhea-AI Summary

Veradigm Inc. (NASDAQ: MDRX) announces that its patient engagement platform, Veradigm FollowMyHealth, has been recognized by KLAS as the Most Improved Software Product in the 2023 Best in KLAS report. This distinction highlights the platform's enhanced customer satisfaction levels over the past year, showcasing its mobile-first approach that elevates patient accessibility and engagement. Veradigm FollowMyHealth aims to foster a collaborative healthcare environment by providing solutions tailored to diverse patient demographics, thereby driving better experiences for both patients and healthcare providers.

Positive

• Recognition as Most Improved Software Product by KLAS strengthens brand reputation.
• Improved customer satisfaction indicates effective enhancements to the FollowMyHealth platform.

Negative

• None.

Veradigm FollowMyHealth customer satisfaction has improved more than any other software solution over the past year, strengthening patient care and experience

CHICAGO--(BUSINESS WIRE)-- Veradigm Inc. (NASDAQ: MDRX), announced today that Veradigm FollowMyHealth (formerly FollowMyHealth), a leading mobile-first patient engagement platform, was recently recognized by KLAS, a prominent healthcare solution evaluator, as Most Improved Software Product in its 2023 Best in KLAS report.

With a mobile-first approach, Veradigm FollowMyHealth helps meet patients on their terms and delivers patient accessibility with an integrated approach to patient engagement. A complete patient care experience promotes a collaborative environment with ease of access and convenience. Veradigm FollowMyHealth offers a real-time gateway across demographic groups, while producing an immediate, proven value for independent practices and health systems. With growing healthcare utilization, Veradigm FollowMyHealth brings timing and technology together, helping improve both the patient and healthcare provider’s experiences.

“As a patient engagement leader for over ten years, Veradigm FollowMyHealth is constantly working to improve our solutions and delight both our clients and the patients that depend on us,” said Kim Franks, Veradigm’s Vice President and General Manager of Consumer. “This recognition by KLAS represents and rewards the focus and hard work our teams put into modernizing and improving our platform. We are proud to be able to provide options to tailor the patient experience in ways that can direct address the needs of our clients in the ever-changing landscape of healthcare.”

About Veradigm®

Veradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions, all working together to transform healthcare insightfully. For more information on Veradigm, visit www.veradigm.com, or find Veradigm on LinkedIn, Facebook, Twitter, and YouTube

View source version on businesswire.com: https://www.businesswire.com/news/home/20230209005325/en/

Investors:

Jenny Gelinas

312-506-1237

jenny.gelinas@veradigm.com

Media:

Concetta Rasiarmos

312-447-2466

concetta.rasiarmos@veradigm.com

Source: Veradigm Inc.

FAQ

What recognition did Veradigm FollowMyHealth receive in 2023?

Veradigm FollowMyHealth was recognized by KLAS as the Most Improved Software Product in its 2023 Best in KLAS report.

How does Veradigm FollowMyHealth improve patient engagement?

The platform utilizes a mobile-first approach to enhance accessibility and improve the patient experience.

What is the stock symbol for Veradigm?

The stock symbol for Veradigm is MDRX.

What improvements have been made to Veradigm FollowMyHealth?

Veradigm FollowMyHealth has implemented updates that have significantly increased customer satisfaction, as recognized by KLAS.

Where is Veradigm Inc. located?

Veradigm Inc. is located in Chicago, Illinois.